Article
Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes.
Neoplasia (New York, N.Y.) - 1 Sept 2016
Tafe Laura J, Pierce Kirsten J, Peterson Jason D, de Abreu Francine, Memoli Vincent A, Black Candice C, Pettus Jason R, Marotti Jonathan D, Gutmann Edward J, Liu Xiaoying, Shirai Keisuke, Dragnev Konstantin H, Amos Christopher I, Tsongalis Gregory J
Abstract excerpt
Detection of somatic mutations in non-small cell lung cancers (NSCLCs), especially adenocarcinomas, is important for directing patient care when targeted therapy is available. Here, we present our experience with genotyping NSCLC using the Ion Torrent Personal Genome Machine (PGM) and the AmpliSeq Cancer Hotspot Panel v2. We tested 453 NSCLC samples from 407 individual patients using the 50 gene AmpliSeq Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
